Trial Profile
Phase II study of chemoradiotherapy with 5-FU plus cisplatin followed by S-1 for clinical stage IA esophageal cancer (definitive chemoradiotherapy)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jul 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Fluorouracil
- Indications Carcinoid tumour; Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 30 Jun 2021 Planned End Date changed from 31 Mar 2023 to 31 Mar 2025.
- 18 Dec 2020 Status changed from recruiting to active, no longer recruiting.
- 19 Dec 2014 New trial record